Skip to main content
. 2017 Nov 4;34(12):193. doi: 10.1007/s12032-017-1049-4

Fig. 1.

Fig. 1

Kaplan–Meier estimates for a time to discontinuation of ziv-aflibercept, b time to discontinuation of concomitant chemotherapy regimen, c overall survival and d progression-free survival. CI confidence interval, SE standard error